Figure 1.
Schematic of mode of action for VEGF signaling and bevacizumab. (A) Free unbound VEGF interacting with the receptor. (B) The monoclonal antibody, bevacizumab, binds to VEGF-A, preventing ligand-receptor interaction and downstream signaling.
Abbreviation: VEGF, vascular endothelial growth factor.
